Cannabis Operators Refinance Ahead of the $3B Debt Wall 💰

Welcome to Advance Genie, weekly newsletter that helps operators in highly stigmatized industries find alternative financing methods.

Between October 1 and early November, two major cannabis MSOs closed $175 million in bank revolvers - Verano with $75 million and Curaleaf with $100 million. Meanwhile Trulieve paid off its $368 million in debt ahead of schedule.

The broader industry faces as much as $3 billion in debt maturing by the end of 2026, with estimates ranging from $2 billion to $3 billion depending on methodology. 

October's refinancing wave shows that top-tier cannabis operators aren't waiting for 2026 to figure out their options. They're locking in bank credit now, at rates that would make traditional businesses envious.

Verano and Curaleaf Close Largest Cannabis Bank Revolvers in Industry History

In October, Verano Holdings closed a $75 million revolving credit facility agented by Chicago Atlantic with participation from a regional bank. 

Chicago Atlantic Managing Partner Peter Sack called it "what we believe to be the largest such facility among US operators in the history of the industry."

The structure provides everything traditional businesses expect from bank credit - and nothing they'd consider unusual.

A floating annual interest rate of SOFR plus 6% with a 4% floor. No required amortization payments. 

Maturity in September 2028. 

Secured by selected real estate with the ability to release collateral proportionately when maintaining 60% loan-to-value ratios. Repayment allowed any time in $2.5 million increments.

Verano immediately drew $50 million to pay down higher-interest debt from its existing senior secured credit facility without incurring prepayment penalties. 

The remaining $25 million sits available for strategic initiatives.

Curaleaf followed weeks later, closing an upsized $100 million revolving line of credit. 

The deals aren't happening in a vacuum. Both companies generate significant operating cash flow - Verano operates across multiple states with strong market positions, while Curaleaf reported $53 million in operating cash flow and $37 million in free cash flow during Q3.

The new $100 million revolver provides runway to manage this while preserving operational flexibility.

Both revolvers share the same foundation: owned real estate as collateral, consistent positive cash flow, and multi-quarter operating track records. 

These aren't distressed borrowers seeking rescue capital. They're profitable operations using bank credit strategically to optimize their capital structures.

Trulieve Takes the Nuclear Option

Rather than refinance, Trulieve Cannabis chose to eliminate the problem entirely. 

The Florida-based MSO announced that it will pay off $368 million in outstanding debt - the full amount of its 8% loan plus interest - by December 25, well before the 2026 due date.

The move removes Trulieve from the list of major MSOs facing what some observers call a "debt tsunami."

The company still owes $110 million at 7.9%, but eliminating the largest maturity removes its biggest refinancing risk.

The company chose to deploy cash now rather than face refinancing uncertainty in 2026.

Three major refinancings in 30 days show a pattern. All three companies acted in Q4 2025, well ahead of their 2026 maturities. 

This preserved negotiating leverage and provided multiple refinancing options. Companies waiting until maturity dates approach will have fewer choices and less favorable terms.

When Bank Credit Isn't Available

Not every cannabis operator qualifies for bank revolvers. 

Understanding what capital actually costs - and what happens when refinancing fails - helps explain why October's deals matter.

Chicago Atlantic's Q3 earnings call provided rare transparency into cannabis financing economics. 

The specialty REIT maintains a cannabis pipeline of approximately $441 million and holds an active loan portfolio of around $400 million across 26 portfolio companies.

The portfolio's weighted average yield to maturity sits at 16.5%. 

The loan-to-enterprise value ratio runs 43.5% with real estate coverage of 1.2x. Only about 14% of the total loan portfolio remains exposed to further rate declines based on the current 7% prime rate.

Co-CEO Peter Sack explained their approach during the earnings call: "We think Virginia is a very attractive medical market...and we think it will be an extremely attractive recreational market as well."

This creates a financing ecosystem with multiple tiers. 

Bank revolvers at SOFR+6% for top-tier operators with pristine collateral and cash flow. 

Specialty REITs at 16%+ yields for operators with strong real estate but less traditional credit profiles. 

Private term loans somewhere in between, providing runway at a cost.

The gap between these tiers reflects risk, but also opportunity. Operators who can't access bank credit today may qualify tomorrow by improving collateral positions, building cash flow track records, or cleaning up operational issues. 

Chicago Atlantic's $441 million pipeline signals that capital remains available across the spectrum.

Hemp Ban and Market Consolidation

The Senate's November 9 hemp THC prohibition adds another variable to 2026 planning. 

The legislation redefines "hemp" to exclude intoxicating cannabinoid products, limiting products to 0.3% total THC and 0.4 milligrams THC per container.

The U.S. Hemp Roundtable, an industry lobby group, estimates the ban threatens a $28.4 billion industry employing 300,000 people.

If enacted, the provisions would eliminate 95% of the current hemp-derived cannabinoid market and result in $1.5 billion in lost state tax revenue, according to the organization.

For licensed cannabis operators, the ban eliminates gray-market competition from hemp-derived THC products sold at gas stations, convenience stores and online without regulatory oversight. 

The timing creates both pressure and opportunity. 

Cannabis operators facing 2026 debt maturities must refinance during the same period that hemp competitors face elimination. 

Those who successfully refinance may emerge into a market with significantly less competition from unregulated products.

Why October's Refinancing Deals Matter

Three cannabis companies closed $175 million in bank credit during October while a fourth paid off $368 million early. 

This happened while the industry faces $3-6 billion in maturities through 2026 and federal hemp prohibition threatens to reshape market dynamics.

The deals prove that institutional capital remains available for cannabis operators with strong fundamentals. 

Bank revolvers. Specialty REIT financing. Private term loans providing runway between these extremes. 

The financing ladder has multiple rungs.

The pattern emerging from October is clear: cannabis operators with owned real estate and positive cash flow can refinance on reasonable terms. 

Those without these fundamentals face narrower options. And companies that wait until maturity dates approach will discover their choices have narrowed significantly.

How To Get Started Today 👇

Building something bold in a high-friction industry?

In a few guided steps, we’ll map your model to the right financing paths and show exactly what you can expect.

👉 Take the quiz